TABLE 3

Qualitative implications of sarcopenia (with or without abdominal obesity)

Sarcopenia (group A)Sarcopenia+abdominal obesity (group B)No sarcopenia (group C)Significant difference between group
Patients n9634168 
Men
 Muscle strength/ASM Nm·kg−14.2 (3.4–5.4)4.7 (4.0–5.45)5.2 (4.3–6.0)A–BC, B–C
 Peak workload/ASM W·kg−13.2 (2.3–3.8)3.2 (2.6–4.1)3.6 (3.2–4.6)AB–C
VO2peak/ASM mL·kg−147.6 (40.2–53.8)49.4 (41.9–60.4)55.0 (49.3–60.7)AB–C
 CET/ASM s·kg−19.9 (7.2–12.1)11.5 (8.4–16.1)13.5 (10.6–20.8)A–BC
Women
 Muscle strength/ASM Nm·kg−14.5 (3.9–5.1)5.0 (4.4–5.7)4.7 (3.7–5.7)A–B
 Peak workload/ASM W·kg−14.0 (3.1–5.3)4.1 (3.3–4.9)4.4 (3.8–4.9)ns
VO2peak/ASM mL·kg−160.3 (51.7–70.7)65.7 (56.7–73.8)73.1 (57.2–74.9)ns
 CET/ASM s·kg−117.8 (12.4–23.2)16.4 (11.9–23.2)14.1 (10.1–27.2)ns
  • Data are presented as median (interquartile range), unless otherwise stated. Comparison of significant physical functioning measures expressed per kilogram appendicular skeletal muscle (ASM) across body composition phenotypes. VO2peak: peak oxygen uptake; CET: cycle endurance time; ns: nonsignificant.